Skip to content

Evaluating the effects of yogurt containing probiotics in treating gastroesophageal reflux disease

Evaluation of the effects of yogurt containing probiotics in treating gastroesophageal reflux disease: a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190831044653N4
Enrollment
120
Registered
2020-01-30
Start date
2019-11-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease (GERD). Gastro-esophageal reflux disease

Interventions

Intervention 1: Intervention group: Ordinary yogurt. Intervention 2: Intervention group: Probiotics yogurt. Intervention 3: Control group: Omeprazole.

Sponsors

Bojnourd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The patient be literate or someone helps him/her in filling the questionnaires Patients should be geographically accessible

Exclusion criteria

Exclusion criteria: Age less than 18 years Allergy to dairy products Pregnancy History of gastrointestinal malignancy History of gastric and esophageal surgery and small bowel bypass Liver and kidney and heart dysfunction Concomitant use of NSAIDs and aspirin for up to one week before the study Anticancer or antibiotic use during 4 weeks before referral and participation in this study No anti-acid, hydrogen pump inhibitors, H2 receptor inhibitors in two groups of yogurt recipients during the study Receiving bisphosphenate, cortisone, potassium chloride or iron tablets concurrently in the study Patient's compliance be less than 80% (self-reported by patient)

Design outcomes

Primary

MeasureTime frame
Effect on the GERD severity. Timepoint: Baseline, one month and tow months later. Method of measurement: The Gastroesophageal Reflux Disease-Health Related Quality of Life instrument (related to typical symptoms).;Effect on the severity of GERD atypical symptoms. Timepoint: Baseline, one month and tow months late. Method of measurement: Reflux Symptom Index and Disease Specific Quality of Life Index questionnaires (related to atypical symptoms).

Secondary

MeasureTime frame
Assessment of quality of life. Timepoint: At baseline, one month and tow months later. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Javad Pournaghi

Bojnourd University of Medical Sciences

pournaghij861@yahoo.com+98 58 3221 0510

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026